Sartorius Stedim (France) Today
| DIM Stock | EUR 168.60 0.55 0.33% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Sartorius Stedim is trading at 168.60 as of the 22nd of November 2024, a 0.33% up since the beginning of the trading day. The stock's open price was 168.05. Sartorius Stedim has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Sartorius Stedim Biotech are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of October 2024 and ending today, the 22nd of November 2024. Click here to learn more.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTORIUS STED operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. The company has 92.17 M outstanding shares. More on Sartorius Stedim Biotech
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sartorius Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sartorius Stedim's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sartorius Stedim or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Medical Instruments & Supplies, Healthcare, Computing (View all Sectors) |
Sartorius Stedim Biotech (DIM) is traded on Euronext Paris in France and employs 11,934 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 28.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Stedim's market, we take the total number of its shares issued and multiply it by Sartorius Stedim's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sartorius Stedim Biotech operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 92.17 M outstanding shares.
Sartorius Stedim Biotech has accumulated about 161.7 M in cash with 612.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.75.
Check Sartorius Stedim Probability Of Bankruptcy
Ownership AllocationSartorius Stedim Biotech shows a total of 92.17 Million outstanding shares. Sartorius Stedim Biotech has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 73.81 % of Sartorius Stedim outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sartorius Ownership Details
Sartorius Stedim Biotech Risk Profiles
Although Sartorius Stedim's alpha and beta are two of the key measurements used to evaluate Sartorius Stedim's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.0 | |||
| Semi Deviation | 2.62 | |||
| Standard Deviation | 3.33 | |||
| Variance | 11.1 |
Sartorius Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sartorius Stedim without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Sartorius Stedim Corporate Management
Elected by the shareholders, the Sartorius Stedim's board of directors comprises two types of representatives: Sartorius Stedim inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Stedim's management team and ensure that shareholders' interests are well served. Sartorius Stedim's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Stedim's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Petra Kirchhoff | Head IR | Profile | |
| Heiko Imhl | VP Relations | Profile | |
| Olivier Guitard | Head BPS | Profile | |
| Joachim Kreuzburg | Chairman CEO | Profile | |
| John Mackay | Sales Marketing | Profile | |
| Benedikt Orzelek | Head Relations | Profile |
Other Information on Investing in Sartorius Stock
Sartorius Stedim financial ratios help investors to determine whether Sartorius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.